Silver Book Fact

New medicines, or “new chemical entities” accounted for 40% (0.8 years) of the two-year gain in life expectancy seen in 52 countries from 1986-2000.

Lichtenberg F. The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. National Bureau of Economic Research. June 2003; Working Paper No. 9754. http://www.nber.org/papers/w9754

Reference

Title
The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001
Publication
National Bureau of Economic Research
Publication Date
June 2003
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Increased longevity added about $3.2 trillion per year to national wealth between 1970 and 2000, an uncounted value equal to approximately 1/2 of the average annual GDP during that period.  
  • Spending $11,000 on general medical care adds an average of 1 year of life. Spending only $1,345 on pharmaceutical research and development yields the same return.  
  • Benefit of Increased Health Care Spending: Disability rates declining for seniors, 1982-1999  
  • Delaying the onset of Alzheimer’s disease, innovations that delay disability among the elderly through 2009, and a 25% increase in efficiency and effectiveness of cancer treatment would save $138 billion…  
  • Increased Use of Medicines Reduces Overall Health Care Costs: Mental health/substance abuse (MH/SA) spending per patient fell as drug spending increased, 1992-1999